Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation

被引：3
|
作者：
Kim, Bo Hyun [1 ]
Park, Joong-Won [1 ]
机构：
[1] Natl Canc Ctr, Ctr Liver Canc, 323 Ilsan Ro, Goyang 10408, South Korea
来源：
JOURNAL OF KOREAN MEDICAL SCIENCE | 2018年 / 33卷 / 45期
关键词：
D O I：
10.3346/jkms.2018.33.e286
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TOLERABILITY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY.
    Dharancy, S.
    Romano, O.
    Lohro, R.
    Pageaux, G. P.
    De Ledinghen, V.
    Hurtova, M.
    Vanlemmens, C.
    Salame, E.
    Cattan, S.
    Boleslamski, E.
    Mathurin, R.
    Pruvot, F. R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S216 - S216
  • [32] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
    Invernizzi, Federica
    Iavarone, Massimo
    Zavaglia, Claudio
    Mazza, Stefano
    Maggi, Umberto
    Cesarini, Lucia
    Antonelli, Barbara
    Airoldi, Aldo
    Manini, Matteo Angelo
    Sangiovanni, Angelo
    Rossi, Giorgio
    Donato, Maria Francesca
    Belli, Luca Saverio
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E560 - E561
  • [33] TOLERABILITY AND EFFICACY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY
    Dharancy, Sebastien
    Romano, Olivier
    Lorho, Richard
    Pageaux, Georges Philippe
    de Ledinghen, Victor
    Hurtova, Monika
    Vanlemmens, Claire
    Salame, Ephrem
    Wolf, Philippe
    Dumortier, Jerome
    Hilleret, Marie Noelle
    Cattan, Stephane
    Mathurin, Philippe
    Pruvot, Francois Rene
    [J]. HEPATOLOGY, 2008, 48 (04) : 310A - 310A
  • [34] Lenvatinib versus sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
    Perera, S.
    Magyar, C. T. J.
    Rajendran, L.
    Li, Z.
    Almugbel, F. A.
    Feng, S.
    Choi, W. J.
    Aceituno, L.
    Selzner, N.
    Jaeckel, E.
    Falla-Rad, N.
    Knox, J. J.
    Chen, E. X.
    O'Kane, G. M.
    Sapisochin, G.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S82 - S83
  • [35] Sorafenib for hepatocellular carcinoma before liver transplantation
    Adair, Anya
    Wigmore, Stephen J.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 (11) : E100 - E101
  • [36] Hepatocellular Carcinoma: Sorafenib Before Liver Transplantation?
    Braillon, Alain
    [J]. HEPATOLOGY, 2010, 51 (06) : 2232 - 2233
  • [37] Sorafenib for Hepatocellular Carcinoma after Living Donor Liver Transplantation.
    Chen, Chao-Long
    Concejero, Allan M.
    Lin, Chih-Che
    Wang, Chih-Chi
    Wang, Shih-Ho
    Liu, Yueh-Wei
    Yong, Chee-Chien
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S161 - S161
  • [38] Sorafenib Reduced Recurrence of Large Hepatocellular Carcinoma after Liver Transplantation
    Asham, Emad
    Boktour, Maha
    Mcfaden, Robert
    Monsour, Howard
    Gaber, Osama
    Ghobrial, R. Mark
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 88 - 88
  • [39] Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
    Gomez-Martin, Carlos
    Bustamante, Javier
    Castroagudin, Javier F.
    Salcedo, Magdalena
    Garralda, Elena
    Testillano, Milagros
    Herrero, Ignacio
    Matilla, Ana
    Sangro, Bruno
    [J]. LIVER TRANSPLANTATION, 2012, 18 (01) : 45 - 52
  • [40] Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?
    Perricone, Giovanni
    Mancuso, Andrea
    Belli, Luca S.
    Mazzarelli, Chiara
    Zavaglia, Claudio
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (05) : 577 - 578
12345